Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Endlicher

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Digestion|November 7, 2013
Hypoxia induces the expression of transketolase-like 1 in human colorectal cancerS Bentz, A Cee, E Endlicher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2013
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)H Fensterer, C Schade-Brittinger, H-H Müller, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Digestion|November 7, 2013
Hypoxia induces the expression of transketolase-like 1 in human colorectal cancerS Bentz, A Cee, E Endlicher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2013
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)H Fensterer, C Schade-Brittinger, H-H Müller, et al.
Pageof 4